Abstract
Can gold therapy be used more safely in rheumatoid arthritis? Adverse drug reactions are more likely in patients with nodular disease, independent of HLA-DR3 status.
Preeti Shah, Sian M Griffith, Michael F Shadforth, June Fisher, Peter T Dawes, Kay V Poulton, Wendy Thomson, William E R Ollier and Derek L Mattey
The Journal of Rheumatology October 2004, 31 (10) 1903-1905;
Preeti Shah
Sian M Griffith
Michael F Shadforth
June Fisher
Peter T Dawes
Kay V Poulton
Wendy Thomson
William E R Ollier
In this issue
Can gold therapy be used more safely in rheumatoid arthritis? Adverse drug reactions are more likely in patients with nodular disease, independent of HLA-DR3 status.
Preeti Shah, Sian M Griffith, Michael F Shadforth, June Fisher, Peter T Dawes, Kay V Poulton, Wendy Thomson, William E R Ollier, Derek L Mattey
The Journal of Rheumatology Oct 2004, 31 (10) 1903-1905;
Can gold therapy be used more safely in rheumatoid arthritis? Adverse drug reactions are more likely in patients with nodular disease, independent of HLA-DR3 status.
Preeti Shah, Sian M Griffith, Michael F Shadforth, June Fisher, Peter T Dawes, Kay V Poulton, Wendy Thomson, William E R Ollier, Derek L Mattey
The Journal of Rheumatology Oct 2004, 31 (10) 1903-1905;